" class="no-js "lang="en-US"> Dr. Blackford Middleton Joins ClosedLoop to Improve Clinical Decisions With AI - Pharmtech Focus
Friday, January 27, 2023

Dr. Blackford Middleton Joins ClosedLoop to Improve Clinical Decisions With AI

ClosedLoop, healthcare’s data science platform, today announced that renowned clinical informatics expert Dr. Blackford Middleton has joined ClosedLoop as Chief Medical Officer. Dr. Middleton and ClosedLoop share a mission to improve every healthcare decision with AI-driven insights, and his decades of experience designing, implementing, and evaluating advanced clinical systems will accelerate ClosedLoop’s progress towards achieving this goal.

At ClosedLoop, Dr. Middleton will help identify relevant informatics standards, support clinical content development and use, and assist in company strategy, product design, and customer success. His perspective and expertise as a national leader on interoperability, healthcare data, provider – and patient-facing systems will help ClosedLoop address some of the industry’s biggest challenges and continue its pursuit of the Quadruple Aim: improving population health, lowering costs, and improving both the patient and provider experience.

“Blackford is deeply passionate about improving healthcare with AI and machine learning at scale, and we are thrilled to have him join the executive team,” said Andrew Eye, CEO and founder. “His understanding of the healthcare delivery system is second to none, and his insight will be invaluable on our journey to help everyone achieve better health outcomes.”

“ClosedLoop is the leader in predictive AI for healthcare—winning the CMS AI Health Outcomes Challenge is testament to that,” said Dr. Middleton. “I’m thrilled to join a leading-edge company that is enabling informaticians and data scientists to transform healthcare delivery. Just having electronic health records (EHRs) in place nationwide is not enough, it is now time to realize their full potential with AI and effectively utilize all available health data to improve care.”

People In This Post

Companies In This Post

  1. Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Read more
  2. Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs Read more
  3. Sharecare Launches VR Program to Improve Well-being of American Workforce Read more
  4. Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer Read more
  5. Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment Read more